Detalhe da pesquisa
1.
Loss of function of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular breast cancer.
Ann Oncol
; 30(1): 115-123, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30423024
2.
Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer.
Ann Oncol
; 29(4): 872-880, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29360925
3.
CYP2D6 genotype is not associated with survival in breast cancer patients treated with tamoxifen: results from a population-based study.
Breast Cancer Res Treat
; 166(1): 277-287, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28730340
4.
A case of premature thelarche with no central cause or genetic variants within the estrogen receptor signaling pathway.
J Pediatr Endocrinol Metab
; 22(8): 751-8, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19845126
5.
Steroid receptor coactivator-1 can regulate osteoblastogenesis independently of estrogen.
Mol Cell Endocrinol
; 448: 21-27, 2017 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28286232
6.
A SNP in steroid receptor coactivator-1 disrupts a GSK3ß phosphorylation site and is associated with altered tamoxifen response in bone.
Mol Endocrinol
; 26(2): 220-7, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22174377